VREOF — Vireo Growth Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1771706 ·
Last close
$0.44
Market Cap
$598.52M
52W High
$0.56
52W Low
$0.35
ADV30
373,740
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 106,200,000 | 59,300,000 | 17,700,000 | -20,300,000 | 928,800,000 | 122,400,000 | 634,700,000 |
| Dec 2025 | 104,510,462 | 56,882,219 | 2,615,971 | -20,372,228 | 817,154,292 | 102,229,759 | 509,729,300 |
| Sep 2025 | 91,655,155 | 37,382,999 | 1,612,680 | -26,298,861 | 678,918,509 | 97,151,669 | 432,612,987 |
| Jun 2025 | 48,063,010 | 20,417,847 | 2,710,753 | -14,934,029 | 659,340,259 | 99,134,913 | 390,761,769 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$3,711,491
Investing CF
$8,759,451
Financing CF
$18,419,059
CapEx
$-29,816,673
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.10
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-299,549,469
Inventory
$59,969,928
Receivables
$115,744,476
ST Investments
$1,020,243
EBIT TTM
$-9,656,543
Pretax Income TTM
$-39,910,908
Interest Exp TTM
$30,254,365
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$350,469,280
EBITDA
$45,245,040
Free Cash Flow
$66,416,544
Enterprise Value
$717,774,528
Total Cash
$123,400,000
Total Debt
$403,700,000
Shares Out
1,360,581,362
Trailing EPS
$-0.09
Book Value
$0.28
ROE
-47.5%
ROA
2.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 268,769,268 | 10,159,790 | -68,113,908 | 817,154,292 | 509,729,300 | — | 3,711,491 |
| Dec 2024 | 99,384,221 | 18,067,365 | -28,007,509 | 278,862,918 | 223,299,395 | — | -10,234,550 |
| Dec 2023 | 88,133,163 | 10,579,778 | -25,547,089 | 183,263,719 | 199,307,368 | — | -965,906 |
| Dec 2022 | 74,625,867 | -6,939,365 | -42,457,444 | 159,156,403 | 155,715,519 | — | -18,073,265 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.06
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TRAX | First Tracks Biotherapeutics, Inc. | $595.09M | $17.06 | — |
| ZVRA | ZEVRA THERAPEUTICS, INC. | $610.07M | $10.32 | — |
| GYRE | GYRE THERAPEUTICS, INC. | $576.35M | $5.94 | — |
| ARVN | ARVINAS, INC. | $575.53M | $8.92 | — |
| ALT | Altimmune, Inc. | $569.81M | $2.93 | — |
News headlines (Yahoo Finance, 1h cache)
Vireo Growth to Buy Bridgewell Agribusiness LLC
2026-05-25 14:55 · Yahoo
Vireo Growth Inc. to Acquire Bridgewell Agribusiness LLC
2026-05-25 11:30 · Yahoo
VREOF: Vireo Growth’s Strong Revenue Growth Supports Price Target of $1.50
2026-05-14 14:15 · Yahoo
Vireo Growth Inc (VREOF) Q1 2026 Earnings Call Highlights: Strategic Acquisitions Propel ...
2026-05-12 19:01 · Yahoo
Vireo Growth Inc. Announces First Quarter 2026 Results
2026-05-12 11:30 · Yahoo
Vireo Growth Inc. to Release First Quarter Results on May 12, 2026
2026-05-06 20:57 · Yahoo
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
2026-05-04 15:11 · Yahoo
Vireo Growth to Acquire FLUENT in All-Stock Transaction
2026-04-30 11:30 · Yahoo
Glass House Brands Announces California Retail Joint Venture with Vireo Growth
2026-04-13 11:30 · Yahoo
Vireo Growth Announces California Retail Joint Venture with Glass House Brands
2026-04-13 11:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.